HALOZYME THERAPEUTICS, INC. Earnings Per Share (Diluted)
HALOZYME THERAPEUTICS, INC. (HALO) reported Earnings Per Share (Diluted) of $1.90 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $1.90, a 42.86% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $1.22, a 31.18% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$1.16, a 209.13% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $1.43, a 36.19% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for fiscal 2025 was $2.56, a 25.36% decline from fiscal 2024.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was $3.43, a 63.33% increase from fiscal 2023.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was $2.10, a 45.83% increase from fiscal 2022.
- HALOZYME THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was $1.44, a 47.45% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.90 10-Q · filed 2026-08-06 | $3.11 10-Q · filed 2026-08-06 | $1.95 derived: net income ÷ weighted average shares · filed 2026-08-06 | $3.39 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2026-03-31 | $1.22 10-Q · filed 2026-05-11 | $0.07 derived: net income ÷ weighted average shares · filed 2026-05-11 | $1.50 derived: net income ÷ weighted average shares · filed 2026-05-11 | $2.84 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-12-31 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-02-17 | $0.28 derived: net income ÷ weighted average shares · filed 2026-02-17 | $1.62 derived: net income ÷ weighted average shares · filed 2026-08-06 | $2.56 10-K · filed 2026-02-17 | |
| 2025-09-30 | $1.43 10-Q · filed 2025-11-03 | $2.76 derived: net income ÷ weighted average shares · filed 2026-08-06 | $3.68 10-Q · filed 2025-11-03 | $4.74 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-06-30 | $1.33 10-Q · filed 2026-08-06 | $2.26 10-Q · filed 2026-08-06 | $3.32 derived: net income ÷ weighted average shares · filed 2026-08-06 | $4.37 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-03-31 | $0.93 10-Q · filed 2026-05-11 | $1.99 derived: net income ÷ weighted average shares · filed 2026-05-11 | $3.05 derived: net income ÷ weighted average shares · filed 2026-05-11 | $3.77 derived: net income ÷ weighted average shares · filed 2026-05-11 | |
| 2024-12-31 | $1.06 derived: net income ÷ weighted average shares · filed 2026-02-17 | $2.11 derived: net income ÷ weighted average shares · filed 2026-02-17 | $2.84 derived: net income ÷ weighted average shares · filed 2026-02-17 | $3.43 10-K · filed 2026-02-17 | |
| 2024-09-30 | $1.05 10-Q · filed 2025-11-03 | $1.78 derived: net income ÷ weighted average shares · filed 2025-11-03 | $2.37 10-Q · filed 2025-11-03 | $3.02 derived: net income ÷ weighted average shares · filed 2026-02-17 | |
| 2024-06-30 | $0.72 10-Q · filed 2025-08-05 | $1.32 10-Q · filed 2025-08-05 | $1.97 derived: net income ÷ weighted average shares · filed 2026-02-17 | $2.58 derived: net income ÷ weighted average shares · filed 2026-02-17 | |
| 2024-03-31 | $0.60 10-Q · filed 2025-05-06 | $1.25 derived: net income ÷ weighted average shares · filed 2026-02-17 | $1.86 derived: net income ÷ weighted average shares · filed 2026-02-17 | $2.42 derived: net income ÷ weighted average shares · filed 2026-02-17 | |
| 2023-12-31 | $0.65 derived: net income ÷ weighted average shares · filed 2026-02-17 | $1.26 derived: net income ÷ weighted average shares · filed 2026-02-17 | $1.82 derived: net income ÷ weighted average shares · filed 2026-02-17 | $2.10 10-K · filed 2026-02-17 | |
| 2023-09-30 | $0.61 10-Q · filed 2024-10-31 | $1.17 derived: net income ÷ weighted average shares · filed 2024-10-31 | $1.45 10-Q · filed 2024-10-31 | $1.86 derived: net income ÷ weighted average shares · filed 2025-02-18 | |
| 2023-06-30 | $0.56 10-Q · filed 2024-08-06 | $0.84 10-Q · filed 2024-08-06 | $1.26 derived: net income ÷ weighted average shares · filed 2025-02-18 | $1.70 derived: net income ÷ weighted average shares · filed 2025-02-18 | |
| 2023-03-31 | $0.29 10-Q · filed 2024-05-07 | $0.70 derived: net income ÷ weighted average shares · filed 2025-02-18 | $1.14 derived: net income ÷ weighted average shares · filed 2025-02-18 | $1.30 derived: net income ÷ weighted average shares · filed 2025-02-18 | |
| 2022-12-31 | $0.41 derived: net income ÷ weighted average shares · filed 2025-02-18 | $0.86 derived: net income ÷ weighted average shares · filed 2025-02-18 | $1.01 derived: net income ÷ weighted average shares · filed 2025-02-18 | $1.44 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.44 10-Q · filed 2023-11-06 | $0.60 derived: net income ÷ weighted average shares · filed 2023-11-06 | $1.02 10-Q · filed 2023-11-06 | $1.49 derived: net income ÷ weighted average shares · filed 2024-02-20 | |
| 2022-06-30 | $0.16 10-Q · filed 2023-08-08 | $0.58 10-Q · filed 2023-08-08 | $1.05 derived: net income ÷ weighted average shares · filed 2024-02-20 | $2.55 derived: net income ÷ weighted average shares · filed 2024-02-20 | |
| 2022-03-31 | $0.43 10-Q · filed 2023-05-09 | $0.89 derived: net income ÷ weighted average shares · filed 2024-02-20 | $2.38 derived: net income ÷ weighted average shares · filed 2024-02-20 | $3.00 derived: net income ÷ weighted average shares · filed 2024-02-20 | |
| 2021-12-31 | $0.46 derived: net income ÷ weighted average shares · filed 2024-02-20 | $1.95 derived: net income ÷ weighted average shares · filed 2024-02-20 | $2.56 derived: net income ÷ weighted average shares · filed 2024-02-20 | $2.74 10-K · filed 2024-02-20 | |
| 2021-09-30 | $1.48 10-Q · filed 2022-11-08 | $2.09 derived: net income ÷ weighted average shares · filed 2022-11-08 | $2.28 10-Q · filed 2022-11-08 | $2.78 derived: net income ÷ weighted average shares · filed 2022-11-08 | |
| 2021-06-30 | $0.62 10-Q · filed 2022-08-09 | $0.81 10-Q · filed 2022-08-09 | $1.31 derived: net income ÷ weighted average shares · filed 2022-08-09 | $1.57 derived: net income ÷ weighted average shares · filed 2022-08-09 | |
| 2021-03-31 | $0.19 10-Q · filed 2022-05-10 | $0.69 derived: net income ÷ weighted average shares · filed 2022-05-10 | $0.95 derived: net income ÷ weighted average shares · filed 2022-05-10 | $1.14 derived: net income ÷ weighted average shares · filed 2022-05-10 | |
| 2020-12-31 | $0.50 10-K · filed 2021-02-23 | $0.76 derived: net income ÷ weighted average shares · filed 2021-11-02 | $0.95 derived: net income ÷ weighted average shares · filed 2021-11-02 | $0.91 10-K · filed 2023-02-21 | |
| 2020-09-30 | $0.25 10-Q · filed 2021-11-02 | $0.44 derived: net income ÷ weighted average shares · filed 2021-11-02 | $0.40 10-Q · filed 2021-11-02 | $0.15 derived: net income ÷ weighted average shares · filed 2021-11-02 | |
| 2020-06-30 | $0.19 10-Q · filed 2021-08-09 | $0.14 10-Q · filed 2021-08-09 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-08-09 | -$0.28 derived: net income ÷ weighted average shares · filed 2021-08-09 | |
| 2020-03-31 | -$0.04 10-Q · filed 2021-05-10 | -$0.29 derived: net income ÷ weighted average shares · filed 2021-05-10 | -$0.46 derived: net income ÷ weighted average shares · filed 2021-05-10 | -$0.56 derived: net income ÷ weighted average shares · filed 2021-05-10 | |
| 2019-12-31 | -$0.24 10-K · filed 2021-02-23 | -$0.41 derived: net income ÷ weighted average shares · filed 2021-02-23 | -$0.51 derived: net income ÷ weighted average shares · filed 2021-02-23 | -$0.50 10-K · filed 2022-02-22 | |
| 2019-09-30 | -$0.17 10-K · filed 2021-02-23 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-02-23 | -$0.26 10-Q · filed 2020-11-02 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-02-23 | |
| 2019-06-30 | -$0.10 10-K · filed 2021-02-23 | -$0.09 10-Q · filed 2020-08-10 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-02-23 | -$0.29 derived: net income ÷ weighted average shares · filed 2021-02-23 | |
| 2019-03-31 | $0.01 10-K · filed 2021-02-23 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-02-23 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-02-23 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-02-23 | |
| 2018-12-31 | -$0.01 10-K · filed 2020-02-24 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-02-24 | -$0.37 derived: net income ÷ weighted average shares · filed 2020-02-24 | -$0.56 10-K · filed 2021-02-23 | |
| 2018-09-30 | -$0.19 10-K · filed 2020-02-24 | -$0.35 derived: net income ÷ weighted average shares · filed 2020-02-24 | -$0.55 10-Q · filed 2018-11-06 | $0.32 derived: net income ÷ weighted average shares · filed 2020-02-24 | |
| 2018-06-30 | -$0.16 10-K · filed 2020-02-24 | -$0.35 derived: net income ÷ weighted average shares · filed 2020-02-24 | $0.51 derived: net income ÷ weighted average shares · filed 2020-02-24 | $0.53 derived: net income ÷ weighted average shares · filed 2020-02-24 | |
| 2018-03-31 | -$0.19 10-K · filed 2020-02-24 | $0.67 derived: net income ÷ weighted average shares · filed 2020-02-24 | $0.69 derived: net income ÷ weighted average shares · filed 2020-02-24 | $0.48 derived: net income ÷ weighted average shares · filed 2020-02-24 | |
| 2017-12-31 | $850.00 10-K · filed 2019-02-21 | $0.85 10-K · filed 2018-02-20 | $0.88 derived: net income ÷ weighted average shares · filed 2019-02-21 | $0.68 derived: net income ÷ weighted average shares · filed 2019-02-21 | $0.45 10-K · filed 2020-02-24 |
| 2017-09-30 | $20.00 10-K · filed 2019-02-21 | $0.02 10-Q · filed 2017-11-07 | -$0.20 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$0.45 10-Q · filed 2018-11-06 | -$0.66 derived: net income ÷ weighted average shares · filed 2019-02-21 |
| 2017-06-30 | -$230.00 10-K · filed 2019-02-21 | -$0.23 10-K · filed 2018-02-20 | -$0.48 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$0.70 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$0.92 derived: net income ÷ weighted average shares · filed 2019-02-21 |
| 2017-03-31 | -$260.00 10-K · filed 2019-02-21 | -$0.26 10-K · filed 2018-02-20 | -$0.47 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$0.69 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$0.89 derived: net income ÷ weighted average shares · filed 2019-02-21 |
| 2016-12-31 | $0.03 10-K · filed 2017-02-28 | -$0.44 derived: net income ÷ weighted average shares · filed 2018-02-20 | -$0.64 derived: net income ÷ weighted average shares · filed 2018-02-20 | -$0.81 10-K · filed 2019-02-21 | |
| 2016-09-30 | -$0.23 10-Q · filed 2017-11-07 | -$0.19 10-K · filed 2017-02-28 | -$0.43 derived: net income ÷ weighted average shares · filed 2018-02-20 | -$0.59 10-Q · filed 2017-11-07 | -$0.80 derived: net income ÷ weighted average shares · filed 2018-02-20 |
| 2016-06-30 | $0.02 10-K · filed 2017-02-28 | -$0.21 10-Q · filed 2016-08-09 | -$0.37 10-Q · filed 2016-08-09 | -$0.57 derived: net income ÷ weighted average shares · filed 2018-02-20 | -$0.80 derived: net income ÷ weighted average shares · filed 2018-02-20 |
| 2016-03-31 | -$0.12 10-K · filed 2017-02-28 | -$0.37 derived: net income ÷ weighted average shares · filed 2018-02-20 | -$0.60 derived: net income ÷ weighted average shares · filed 2018-02-20 | -$0.80 derived: net income ÷ weighted average shares · filed 2018-02-20 | |
| 2015-12-31 | $0.03 10-K · filed 2016-02-29 | -$0.44 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.64 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.25 10-K · filed 2018-02-20 | |
| 2015-09-30 | -$0.19 10-K · filed 2016-02-29 | -$0.43 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.28 derived: net income ÷ weighted average shares · filed 2016-11-07 | ||
| 2015-06-30 | $0.02 10-Q · filed 2016-08-09 | -$0.10 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | -$0.12 10-K · filed 2016-02-29 | ||||
| 2014-06-30 | -$0.13 10-Q · filed 2015-08-10 | -$0.35 10-Q · filed 2015-08-10 | |||
| 2012-09-30 | -$0.18 derived: net income ÷ weighted average shares · filed 2014-02-28 | -$0.30 derived: net income ÷ weighted average shares · filed 2014-02-28 | -$0.44 derived: net income ÷ weighted average shares · filed 2013-11-08 | ||
| 2012-06-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2014-02-28 | -$0.27 derived: net income ÷ weighted average shares · filed 2013-08-07 | |||
| 2011-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$0.13 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$0.10 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$0.19 derived: net income ÷ weighted average shares · filed 2014-02-28 | |
| 2011-09-30 | $0.05 10-Q · filed 2011-11-08 | $0.08 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$0.01 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | $0.03 10-Q · filed 2011-08-05 | -$0.06 10-Q · filed 2011-08-05 | |||
| 2011-03-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2013-03-01 | ||||
| 2010-09-30 | -$0.13 10-Q · filed 2011-11-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2011-11-08 | -$0.39 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$0.13 10-Q · filed 2011-08-05 | -$0.26 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |